Back to Search
FRANCISCO RIVERA, M.D.
M.D.
General Practice Physician
NPI: 1508819822Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
15580(PR)
Research & Publications (20)
Calpain inhibitors prevent p38 MAPK activation and germ cell apoptosis after heat stress in pubertal rat testes.
PMID 19598167·J Cell Physiol·2009
7-preclinical
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
PMID 19540072·Int J Radiat Oncol Biol Phys·2009
3-trial
A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis?
PMID 18988707·Stem Cells·2009
7-preclinical
Cross-national associations between parent and peer communication and psychological complaints.
PMID 19639255·Int J Public Health·2009
8-other
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.
PMID 19567451·Ann Oncol·2009
3-trial
Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.
PMID 19370171·Mar Drugs·2009
3-trial
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
PMID 19111473·Crit Rev Oncol Hematol·2009
3-trial
Consensus on the treatment of pancreatic cancer in Spain.
PMID 19451062·Clin Transl Oncol·2009
6-review
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
PMID 19465426·Ann Oncol·2009
4-observational
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
PMID 19451431·J Clin Oncol·2009
3-trial
Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.
PMID 19131170·Cancer Treat Rev·2009
6-review
Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis.
PMID 18354075·Clin J Am Soc Nephrol·2008
4-observational
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.
PMID 18421053·J Clin Oncol·2008
3-trial
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
PMID 18421054·J Clin Oncol·2008
3-trial
Family Cohesion and its Relationship to Psychological Distress among Latino Groups.
PMID 19444326·Hisp J Behav Sci·2008
8-other
Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
PMID 19017933·J Immunol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- STREET 778 KM. 0.9 PASARELL, PABELLON DE SERVICIOS
COMERIO, PR 00782 - Phone
- (787) 875-3136
Quick Facts
- NPI
- 1508819822
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile